NCT02960594 - hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 9, 2018

Study Completion Date

November 9, 2018

Conditions

Breast CancerLung CancerPancreatic CancerHead and Neck CancerOvarian CancerColoRectal CancerGastric CancerEsophageal CancerHepatoCellular Carcinoma

Interventions

BIOLOGICAL

INO-1400

BIOLOGICAL

INO-9012

BIOLOGICAL

INO-1401

Trial Locations (6)

University of Pittsburgh, Pittsburgh

University of Pennsylvania, Philadelphia

Thomas Jefferson University Hospital, Philadelphia

University of North Carolina, Chapel Hill

Barbara Ann Karmanos Cancer Institute, Detroit

Mayo Clinic, Rochester